Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression

PLoS Pathog. 2024 Apr 25;20(4):e1012172. doi: 10.1371/journal.ppat.1012172. eCollection 2024 Apr.

Abstract

The implementation of antiretroviral therapy (ART) has effectively restricted the transmission of Human Immunodeficiency Virus (HIV) and improved overall clinical outcomes. However, a complete cure for HIV remains out of reach, as the virus persists in a stable pool of infected cell reservoir that is resistant to therapy and thus a main barrier towards complete elimination of viral infection. While the mechanisms by which host proteins govern viral gene expression and latency are well-studied, the emerging regulatory functions of non-coding RNAs (ncRNA) in the context of T cell activation, HIV gene expression and viral latency have not yet been thoroughly explored. Here, we report the identification of the Cytoskeleton Regulator (CYTOR) long non-coding RNA (lncRNA) as an activator of HIV gene expression that is upregulated following T cell stimulation. Functional studies show that CYTOR suppresses viral latency by directly binding to the HIV promoter and associating with the cellular positive transcription elongation factor (P-TEFb) to activate viral gene expression. CYTOR also plays a global role in regulating cellular gene expression, including those involved in controlling actin dynamics. Depletion of CYTOR expression reduces cytoplasmic actin polymerization in response to T cell activation. In addition, treating HIV-infected cells with pharmacological inhibitors of actin polymerization reduces HIV gene expression. We conclude that both direct and indirect effects of CYTOR regulate HIV gene expression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Regulation, Viral*
  • HIV Infections* / genetics
  • HIV Infections* / virology
  • HIV-1* / genetics
  • HIV-1* / physiology
  • Humans
  • Jurkat Cells
  • Lymphocyte Activation
  • Promoter Regions, Genetic
  • RNA, Long Noncoding* / genetics
  • Virus Latency*

Substances

  • RNA, Long Noncoding

Grants and funding

This work is supported by the Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 508136175 – FA 378/25-1 to OTF and RT) and the German Centre for Infection Research (DZIF) (TTU 04.820 – HIV reservoir to OTF). OTF is a member of the CellNetworks cluster of excellence (EXC81). Additional funding for RT is from the Bi-National Science Foundation (BSF) - 2021273 to RT and JS and the National Institute of Health -NIH-R21 – 5R21AI170195 for RT and KF. KF is also supported by NIH R01AI167778, and Gilead Mentored Scientist Award from the UCSF AIDS Research Institute (ARI) and a Boost award from the NIH-funded UCSF-Bay Area Center for AIDS Research (P30 AI027763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.